4.6 Article

Therapeutic activity and biodistribution of a nano-sized polymer-dexamethasone conjugate intended for the targeted treatment of rheumatoid arthritis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis

A. Libanska et al.

Summary: This study presents biocompatible and stimuli-sensitive polymer conjugates with an anti-inflammatory drug, dexamethasone, which are designed for prolonged blood circulation, enhanced inflammatory site accumulation, site-specific drug release, and subsequent elimination via urine excretion. The polymer nanomedicines demonstrated the ability to reduce joint inflammation and arthritis-induced bone damage in a mouse model of rheumatoid arthritis.

JOURNAL OF CONTROLLED RELEASE (2023)

Review Medicine, Research & Experimental

Nanomedicine for the Treatment of Rheumatoid Arthritis

Moonkyoung Jeong et al.

Summary: Nanomedicine is a new therapeutic strategy that can efficiently localize drugs in inflamed joints for the treatment of rheumatoid arthritis. It focuses on targeted delivery, controlled drug release, and immune modulation to manage the progression of RA.

MOLECULAR PHARMACEUTICS (2021)

Review Engineering, Biomedical

Nanomedicine Strategies for Anti-Inflammatory Treatment of Noninfectious Arthritis

Long Chen et al.

Summary: Noninfectious arthritis encompasses chronic and progressive inflammatory disorders that require early management. Common forms include osteoarthritis, rheumatoid arthritis, and nanomedicine shows promise in improving therapeutic efficacy while reducing side effects and extending drug half-life.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Medicine, Research & Experimental

Applicability and implementation of the collagen-induced arthritis mouse model, including protocols (Review)

Jing Luan et al.

Summary: Animal models are crucial for studying the pathogenesis of rheumatoid arthritis and evaluating the efficacy of anti-RA drugs, with the CIA mouse model being the most widely used due to its rapid and inexpensive generation and similarity to human RA. This review aims to introduce the CIA model to beginners and clarify important details for reliable results, summarizing information on model origin, pathogenesis, construction protocol, successful arthritis induction rate, and arthritis severity evaluation methods. With this knowledge, researchers can start quickly and avoid unnecessary errors.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Chemistry, Multidisciplinary

ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis via inhibiting iRhom2/TNF-α/BAFF pathways

Yanqin Song et al.

Summary: The study introduced a new liposome nanoformulation Dex@FA-ROS-Lips for precise treatment of rheumatoid arthritis, showing improved therapeutic effect and potential in targeting inflammatory diseases.

NANOSCALE (2021)

Article Chemistry, Multidisciplinary

Structural optimization of HPMA copolymer-based dexamethasone prodrug for improved treatment of inflammatory arthritis

Zhenshan Jia et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Review Pharmacology & Pharmacy

Advanced nanomedicines for the treatment of inflammatory diseases

Romain Brusini et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Article Medicine, Research & Experimental

Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis

Xin Wei et al.

MOLECULAR PHARMACEUTICS (2018)

Article Medicine, General & Internal

Rheumatoid arthritis

Josef S. Smolen et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Review Physiology

Polymer-Drug Conjugates in Inflammation Treatment

E. Koziolova et al.

PHYSIOLOGICAL RESEARCH (2018)

Editorial Material Pharmacology & Pharmacy

Advanced nanomedicine for rheumatoid arthritis treatment: focus on active targeting

Mingli Chen et al.

EXPERT OPINION ON DRUG DELIVERY (2017)

Article Chemistry, Multidisciplinary

Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis

Qin Wang et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Article Rheumatology

Glucocorticoids and Rheumatoid Arthritis

Joana Fonseca Ferreira et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)

Review Pharmacology & Pharmacy

Development of macromolecular prodrug for rheumatoid arthritis

Fang Yuan et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Article Chemistry, Multidisciplinary

Stereogradient Polymers Formed by Controlled/Living Radical Polymerization of Bulky Methacrylate Monomers

Kenji Ishitake et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)

Review Immunology

Cytokines in the pathogenesis of rheumatoid arthritis

Iain B. McInnes et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Review Medicine, General & Internal

Antiinflammatory action of glucocorticoids - New mechanisms for old drugs

T Rhen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)